Nova Patents
AT524192T

Peptide useful in immunomodulation

Abstract

A peptide comprising at least one epitope recognized by BAT monoclonal antibody, selected from a peptide having the sequence of any of SEQ ID Nos 1 to 10 or a salt thereof which maintains the biological activity of the peptide.

Term

Term ended

Expired 15 October 2022, 3.9 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

17 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
14592601IsraelA
0200831IsraelW

Members17

Family members, oldest first
DocumentOfficeKind
WO03033644A2World Intellectual Property Organization (WIPO)A2
AU2002341375A1AustraliaA1
WO03033644A3World Intellectual Property Organization (WIPO)A3
IL160988A0IsraelA0
EP1469869A2European Patent Office (EPO)A2
US2005003397A1United States of AmericaA1
EP1469869A4European Patent Office (EPO)A4
US2006210573A1United States of AmericaA1
US7122372B2United States of AmericaB2
US7329639B2United States of AmericaB2
US2008175855A1United States of AmericaA1
US7745397B2United States of AmericaB2
IL160988AIsraelA
EP1469869B1European Patent Office (EPO)B1
AT524192TThis recordAustriaT
ATE524192T1AustriaT1
ES2373377T3SpainT3